Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabal Mittal

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2024
Warfarin and heparin monitoring in antiphospholipid syndromePrabal Mittal, Zara Sayar, Hannah Cohen
Lupus|September 8, 2022
The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndromeZara Sayar, Shoshana Burke, Prabal Mittal, et al.
Lupus|February 20, 2025
Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapyPedro Gaspar, Prabal Mittal, Hannah Cohen, et al.
Research and Practice in Thrombosis and Haemostasis|February 22, 2024
Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrualPedro Gaspar, Prabal Mittal, Hannah Cohen, et al.
Journal of Clinical Medicine|February 10, 2024
Platelets and Thrombotic Antiphospholipid SyndromeIbrahim Tohidi-Esfahani, Prabal Mittal, David Isenberg, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 26, 2022
Antiphospholipid syndrome, antiphospholipid antibodies, and strokePrabal Mittal, Graziella Quattrocchi, Ibrahim Tohidi-Esfahani, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2023
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesHannah Cohen, David J Werring, Arvind Chandratheva, et al.
Lupus|May 6, 2026
Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteriaRoni Meidan, Monica Angerri Nadal, Blanca Viejo Sosa, et al.
Lupus|August 2, 2024
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective studyPrabal Mittal, Marina Pacheco, Laura Trives-Folguera, et al.
British Journal of Haematology|July 12, 2020
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infectionKatharine Orf, Srdan Rogosic, Daniel Dexter, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Hematology. American Society of Hematology. Education Program|December 7, 2024
Warfarin and heparin monitoring in antiphospholipid syndromePrabal Mittal, Zara Sayar, Hannah Cohen
Lupus|September 8, 2022
The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndromeZara Sayar, Shoshana Burke, Prabal Mittal, et al.
Lupus|February 20, 2025
Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapyPedro Gaspar, Prabal Mittal, Hannah Cohen, et al.
Research and Practice in Thrombosis and Haemostasis|February 22, 2024
Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrualPedro Gaspar, Prabal Mittal, Hannah Cohen, et al.
Journal of Clinical Medicine|February 10, 2024
Platelets and Thrombotic Antiphospholipid SyndromeIbrahim Tohidi-Esfahani, Prabal Mittal, David Isenberg, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 26, 2022
Antiphospholipid syndrome, antiphospholipid antibodies, and strokePrabal Mittal, Graziella Quattrocchi, Ibrahim Tohidi-Esfahani, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2023
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesHannah Cohen, David J Werring, Arvind Chandratheva, et al.
Lupus|May 6, 2026
Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteriaRoni Meidan, Monica Angerri Nadal, Blanca Viejo Sosa, et al.
Lupus|August 2, 2024
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective studyPrabal Mittal, Marina Pacheco, Laura Trives-Folguera, et al.
British Journal of Haematology|July 12, 2020
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infectionKatharine Orf, Srdan Rogosic, Daniel Dexter, et al.
Pageof 2